Table 3.
Changes in l-carnitine concentration during the treatment period.
| l-carnitine Group (n = 67) | Control Group (n = 64) | |||||
|---|---|---|---|---|---|---|
| Baseline | 12 Months | p Value | Baseline | 12 Months | p Value | |
| Total carnitine (μmol/L) | 42.0 ± 11.0 | 243.1 ± 87.4 * | <0.0001 | 40.2 ± 9.7 | 49.9 ± 9.5 | NS |
| Free carnitine (μmol/L) | 27.0 ± 7.8 | 157.6 ± 54.8 * | <0.0001 | 25.9 ± 6.9 | 25.6 ± 6.7 | NS |
| Acyl carnitine (μmol/L) | 15.0 ± 5.0 | 85.6 ± 38.3 * | <0.0001 | 14.2 ± 4.5 | 14.3 ± 4.5 | NS |
| Acyl/free ratio | 0.59 ± 0.27 | 0.54 ± 0.17 | <0.05 | 0.56 ± 0.17 | 0.58 ± 0.19 | NS |
* p < 0.0001 vs. control group. NS, not significant.